Esprinet S.p.A. (BIT:PRT) commences share repurchases on April 20, 2021, under the program mandated by the shareholders in the shareholders' meeting held on April 7, 2021. As per the mandate, the company is authorized to repurchase up to 2,540,706 shares, representing 4.99% of its share capital, company's holding in treasury does not exceed 2,546,706 own shares, representing 5% of its share capital. The maximum price in case of purchase on stock exchange will be in range of -20% and +20% compared to the official price of the business day before the purchase date and in case of public offer the price value will be in range of -30% and +30% compared to the official price of the business day before the purchase date. Minimum share price shall be nominal value. The purpose of the repurchase program is to reduction in share capital, in value or number of shares and fulfilment of obligations arising from share option programs or other assignments of shares to employees or members of the board of directors of the company or its subsidiaries or affiliate. The program will be funded out of available reserves and distributable profits. The share buyback program will be valid for a period of 18 months. As of March 2, 2021, the company had 50,934,123 common shares in issue and 1,150,000 own shares in treasury. On April 19, 2021, the company initiated a Market Repurchase. Under the program, the company will repurchase up to €25 million worth of shares, representing 3% of its issued share capital. The shares will be used used in part to fulfill the obligations of the "Long Term Incentive Plan" 2021-2023 on the free allocation of company shares and, in part, to serve the reduction in the number of shares in circulation. The program will be started on April 20, 2021 and will end by December 31, 2021. As of April 19, 2021, the company has 352,314 treasury shares.